GO:0004438 phosphatidylinositol-3-phosphate phosphatase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004438 describes the enzymatic removal of the 3-phosphate group from phosphatidylinositol 3-phosphate (PI3P), converting it to phosphatidylinositol.
• This activity is catalyzed by myotubularin-related proteins (MTMRs), which are conserved lipid phosphatases.
• Loss of MTMR2 causes X-linked myotubular myopathy, highlighting its role in muscle maintenance.
• MTMR6 negatively regulates the Ca2+-activated K+ channel KCa3.1, linking PI3P turnover to ion transport.
• PI3P phosphatase activity is essential for autophagy, lysosome function, and nutrient sensing.
• Dysregulation of PI3P phosphatases is implicated in neurodevelopmental, neuromuscular, and neurodegenerative disorders.
Description
Phosphatidylinositol-3-phosphate phosphatase activity (GO:0004438) is a molecular function that catalyzes the hydrolysis of phosphatidylinositol 3-phosphate (PI3P) to phosphatidylinositol and inorganic phosphate. This reaction is a key step in the turnover of phosphoinositides, which are critical regulators of membrane trafficking, signal transduction, and autophagy. The enzyme responsible for this activity was first identified as myotubularin, the product of the gene mutated in X-linked myotubular myopathy. Subsequent studies revealed a family of myotubularin-related proteins (MTMRs) that share this enzymatic activity and regulate diverse cellular processes. Researchers study GO:0004438 to understand how cells control PI3P levels, which in turn affect organelle identity, membrane dynamics, and stress responses. The importance of this activity is underscored by its link to human diseases, including myotubular myopathy, Charcot-Marie-Tooth neuropathy, and certain cancers.
phosphatidylinositol-3-phosphate phosphatase activity At A Glance
| GO ID | GO:0004438 |
|---|---|
| GO term | phosphatidylinositol-3-phosphate phosphatase activity |
| Ontology | molecular_function |
| Synonym | phosphatidylinositol-3-phosphatase activity; inositol 1,3-bisphosphate phosphatase activity; phosphatidyl-3-phosphate 3-phosphohydrolase activity |
| Major function | Hydrolyzes phosphatidylinositol 3-phosphate to phosphatidylinositol and phosphate |
| Substrate | 1-phosphatidyl-1D-myo-inositol 3-phosphate (PI3P) |
| Products | 1-phosphatidyl-1D-myo-inositol (phosphatidylinositol) and phosphate |
| Cofactors | None required; some MTMRs may be regulated by phosphorylation or protein interactions |
| Localization | Cytosol, endosomes, and other membrane compartments |
What Is GO:0004438?
GO:0004438 is defined as the catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 3-phosphate + H2O = 1-phosphatidyl-1D-myo-inositol + phosphate. In simpler terms, it is the enzyme activity that removes the phosphate group from the third position of the inositol ring of phosphatidylinositol 3-phosphate (PI3P), producing phosphatidylinositol. This activity is specific for the 3-phosphate and is distinct from other phosphoinositide phosphatases that act on different positions.
Why Is phosphatidylinositol-3-phosphate phosphatase activity Important in Cell Biology?
Phosphatidylinositol-3-phosphate phosphatase activity is crucial for maintaining the proper balance of phosphoinositides, which are key regulators of membrane trafficking, autophagy, and signal transduction. By converting PI3P to phosphatidylinositol, this activity controls the recruitment of effector proteins that contain PI3P-binding domains, thereby influencing processes such as endosomal sorting, lysosome biogenesis, and autophagosome formation. Dysregulation of this activity leads to severe human diseases, including X-linked myotubular myopathy, Charcot-Marie-Tooth disease, and certain cancers. Therefore, understanding GO:0004438 is essential for both basic cell biology and translational research.
• Regulates autophagy and lysosome function by controlling PI3P levels on endosomes.
• Mutations in MTMR2 cause X-linked myotubular myopathy, a severe muscle disorder.
• MTMR6 negatively regulates the Ca2+-activated K+ channel KCa3.1, affecting ion transport and cell volume.
• Implicated in neurodevelopmental and neurodegenerative disorders due to defective autophagy.
• Plays a role in host-pathogen interactions; Rickettsia rickettsii effector modulates PI3K activity and autophagy.
• Potential target for cancer therapy, as PI3P phosphatases can act as tumor suppressors.
• Essential for gut homeostasis; autophagy and microbiota interplay in inflammatory bowel disease.
• Provides a mechanism for nutrient-regulated control of lysosome function via signaling lipid conversion.
Molecular Mechanism of phosphatidylinositol-3-phosphate phosphatase activity
Substrate recognition and binding
In simple terms: The enzyme grabs PI3P and positions it for phosphate removal.
The enzyme specifically binds phosphatidylinositol 3-phosphate (PI3P) through a conserved catalytic domain. Structural studies of myotubularin (MTM1) and MTMR2 have revealed a active site that accommodates the inositol headgroup and the 3-phosphate, while excluding other phosphoinositides. The binding is stabilized by hydrophobic interactions with the lipid acyl chains and electrostatic interactions with the phosphate group.
Catalytic mechanism
In simple terms: A water molecule attacks the phosphate, breaking it off.
The catalytic mechanism involves a nucleophilic water molecule that attacks the phosphorus atom of the 3-phosphate, leading to hydrolysis and release of inorganic phosphate. This reaction is metal-independent and does not require ATP. The enzyme uses a conserved cysteine residue in the active site to form a covalent intermediate, which is then resolved by water.
Product release and membrane dissociation
In simple terms: After cutting off the phosphate, the enzyme lets go of the lipid.
Following hydrolysis, the product phosphatidylinositol remains in the membrane, while the enzyme may dissociate or remain associated depending on its localization signals. Some MTMRs contain PH domains or other membrane-targeting modules that regulate their recruitment to specific organelles.
Regulation by protein-protein interactions
In simple terms: Other proteins can turn the enzyme on or off.
MTMRs are regulated by interactions with partner proteins. For example, MTMR6 is activated by association with the calcium-binding protein KCa3.1, which recruits it to the plasma membrane. Similarly, MTMR2 forms a complex with MTMR13, which is required for its stability and function.
Role in autophagy and lysosome function
In simple terms: This enzyme helps cells recycle waste by controlling lipid signals.
PI3P is essential for autophagosome formation and endosomal sorting. By converting PI3P to phosphatidylinositol, MTMRs negatively regulate autophagy initiation and promote lysosome function. Nutrient availability modulates this activity, as shown by nutrient-regulated control of lysosome function by signaling lipid conversion.
Key Genes Involved in GO:0004438 phosphatidylinositol-3-phosphate phosphatase activity
The following genes encode proteins that possess or regulate phosphatidylinositol-3-phosphate phosphatase activity.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MTM1 | Catalyzes PI3P dephosphorylation; mutations cause X-linked myotubular myopathy | Muscle maintenance, autophagy, and membrane trafficking |
| MTMR2 | PI3P phosphatase; forms complex with MTMR13 | Charcot-Marie-Tooth disease, myotubular myopathy |
| MTMR3 | PI3P phosphatase; regulates autophagy | Autophagy, cancer, and inflammatory bowel disease |
| MTMR4 | PI3P phosphatase; involved in TGF-beta signaling | Cell signaling, cancer |
| MTMR6 | PI3P phosphatase; negative regulator of KCa3.1 | Ion transport, cell volume regulation |
| MTMR7 | PI3P phosphatase; interacts with MTMR9 | Neuronal function, autophagy |
| MTMR8 | PI3P phosphatase; regulates autophagy | Autophagy, cancer |
| MTMR9 | Regulatory subunit for MTMR6 and MTMR7 | Enhances phosphatase activity |
| MTMR13 | Pseudophosphatase; stabilizes MTMR2 | Charcot-Marie-Tooth disease |
| MTMR14 | PI3P phosphatase; regulates autophagy | Muscle function, autophagy |
| PIK3C3 | Kinase that generates PI3P | Autophagy, endosomal trafficking |
| BECN1 | Component of PI3K complex; regulates autophagy | Autophagy, cancer |
| ATG14 | Targets PI3K complex to autophagosomes | Autophagy |
| UVRAG | Regulates PI3K complex in autophagy | Autophagy, cancer |
| KCa3.1 | Calcium-activated potassium channel; regulated by MTMR6 | Ion transport, immune response |
| RAB7 | Late endosome marker; affected by PI3P levels | Endosomal trafficking |
| LAMP1 | Lysosome marker; affected by PI3P turnover | Lysosome function |
How Is phosphatidylinositol-3-phosphate phosphatase activity Regulated?
Phosphatidylinositol-3-phosphate phosphatase activity is regulated at multiple levels. Nutrient availability controls the activity of MTMRs, as shown by nutrient-regulated control of lysosome function by signaling lipid conversion. Protein-protein interactions, such as MTMR6 binding to KCa3.1, modulate enzyme recruitment and activity. Phosphorylation of MTMRs by kinases such as Akt can affect their localization and function. Additionally, the expression levels of MTMRs are regulated by transcription factors and microRNAs, and mutations in MTMR genes cause human diseases.
phosphatidylinositol-3-phosphate phosphatase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MTM1 | X-linked myotubular myopathy | MTM1 knockout mice, patient-derived iPSCs, muscle-specific KO |
| MTMR2 | Charcot-Marie-Tooth disease type 4B | MTMR2 knockout mice, Schwann cell-specific KO |
| MTMR13 | Charcot-Marie-Tooth disease type 4B | MTMR13 knockout mice, co-culture with neurons |
| MTMR6 | Ion transport disorders, immune dysfunction | MTMR6 knockout cells, KCa3.1 patch-clamp |
| MTMR3 | Inflammatory bowel disease, cancer | MTMR3 knockout mice, colitis models |
X-linked myotubular myopathy
Mutations in MTM1, which encodes a PI3P phosphatase, cause X-linked myotubular myopathy, a severe congenital muscle disorder characterized by hypotonia and respiratory failure. Lack of myotubularin phosphatase activity is the main cause of the disease, leading to impaired autophagy and membrane trafficking in muscle cells.
Charcot-Marie-Tooth disease
Mutations in MTMR2 and MTMR13 cause Charcot-Marie-Tooth disease type 4B, a demyelinating neuropathy. Loss of PI3P phosphatase activity leads to abnormal endosomal trafficking and myelin abnormalities in Schwann cells.
Neurodegenerative and neurodevelopmental disorders
Defective autophagy, often due to impaired PI3P turnover, is linked to neurodevelopmental, neuromuscular, and neurodegenerative disorders. Mutations in MTMRs and other autophagy-related genes contribute to these conditions.
Inflammatory bowel disease and infection
Autophagy and gut microbiota interplay are critical in inflammatory bowel disease. PI3P phosphatases regulate autophagy, and their dysfunction may contribute to chronic inflammation. Additionally, Rickettsia rickettsii exploits PI3K activity and autophagy for virulence, highlighting the role of PI3P metabolism in infection.
From phosphatidylinositol-3-phosphate phosphatase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of MTM1 cause myotubular myopathy? | MTM1 knockout mouse or patient iPSC-derived myotubes |
| How does MTMR6 regulate KCa3.1? | MTMR6 knockout HEK293 cells with KCa3.1 overexpression |
| What is the role of MTMR3 in autophagy? | MTMR3 knockout HeLa cells, LC3 flux assay |
| Does MTMR2 mutation affect myelination? | MTMR2 knockout zebrafish or mouse Schwann cells |
| How does PI3P phosphatase activity affect lysosome function? | MTMR overexpression in HeLa cells, lysosome pH and enzyme activity assays |
| Can MTMR14 rescue muscle function? | MTMR14 knock-in mouse model of myotubular myopathy |
How to Study the phosphatidylinositol-3-phosphate phosphatase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Malachite green assay | Phosphate release from PI3P | Enzyme kinetics of MTMRs |
| GFP-2xFYVE biosensor | PI3P levels on endosomes | Live-cell imaging of lipid dynamics |
| LC3 flux assay | Autophagosome turnover | Autophagy regulation by MTMRs |
| Immunoprecipitation-MS | Protein-protein interactions | Identification of MTMR complexes |
| CRISPR knockout | Loss of gene function | Phenotypic analysis of MTMR genes |
| RNA-seq | Transcriptional changes | Pathway analysis in MTMR-deficient cells |
| Patch-clamp | Ion channel activity | KCa3.1 regulation by MTMR6 |
Measuring phosphatase activity
In vitro phosphatase assays using synthetic PI3P substrates and malachite green or fluorescent probes can directly measure GO:0004438 activity. These assays are used to validate enzyme kinetics and inhibitor effects.
Live-cell imaging of PI3P dynamics
Genetically encoded PI3P biosensors (e.g., GFP-2xFYVE) allow real-time visualization of PI3P levels in live cells. This method reveals how MTMRs modulate PI3P on endosomes and autophagosomes.
Autophagy flux analysis
LC3-II turnover, p62 degradation, and electron microscopy are used to assess autophagic flux in cells with modulated PI3P phosphatase activity. These methods link GO:0004438 to autophagy regulation.
Proteomics and interactomics
Affinity purification coupled with mass spectrometry identifies protein partners of MTMRs, such as MTMR13 and KCa3.1, providing insights into regulation and downstream effects.
How CRISPR Can Be Used to Study GO:0004438 phosphatidylinositol-3-phosphate phosphatase activity
Knockout
CRISPR knockout of MTMR genes (e.g., MTM1, MTMR2, MTMR6) in cell lines or animal models allows researchers to study loss-of-function phenotypes, such as impaired autophagy, lysosome dysfunction, and ion transport defects.
Point Mutation
Introducing disease-associated point mutations (e.g., MTM1 mutations found in myotubular myopathy) via CRISPR base editing or HDR enables precise modeling of enzymatic defects and genotype-phenotype correlations.
Knock-in
Knock-in of tagged MTMR alleles (e.g., GFP or HA tags) facilitates live-cell imaging and proteomic analysis of PI3P phosphatase localization and interactions.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of MTMRs can be used to increase PI3P phosphatase activity, allowing gain-of-function studies on autophagy suppression and lysosome function.
How EDITGENE Supports phosphatidylinositol-3-phosphate phosphatase activity Research
Researchers studying phosphatidylinositol-3-phosphate phosphatase activity-related genes often need to determine whether a candidate gene is causally involved in a specific cellular process or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise genetic manipulation and functional interrogation of these genes.
Contact EDITGENE today to design your custom CRISPR model for phosphatidylinositol-3-phosphate phosphatase activity research.
Frequently Asked Questions About phosphatidylinositol-3-phosphate phosphatase activity
What is phosphatidylinositol-3-phosphate phosphatase activity?
It is the enzyme activity that removes the phosphate group from phosphatidylinositol 3-phosphate (PI3P), converting it to phosphatidylinositol and phosphate, as defined by GO:0004438.
What genes are involved in phosphatidylinositol-3-phosphate phosphatase activity?
The main genes are MTM1, MTMR2, MTMR3, MTMR4, MTMR6, MTMR7, MTMR8, MTMR14, and others in the myotubularin-related family.
What diseases are associated with phosphatidylinositol-3-phosphate phosphatase activity?
Mutations in MTM1 cause X-linked myotubular myopathy, and mutations in MTMR2 or MTMR13 cause Charcot-Marie-Tooth disease. Dysregulation is also linked to neurodegenerative disorders and cancer.
How is phosphatidylinositol-3-phosphate phosphatase activity regulated?
It is regulated by nutrient availability, protein-protein interactions (e.g., MTMR6 with KCa3.1), and phosphorylation.
What is the role of PI3P phosphatase in autophagy?
By dephosphorylating PI3P, these enzymes negatively regulate autophagy initiation and promote lysosome function, affecting autophagosome formation and cargo degradation.
Which proteins have phosphatidylinositol-3-phosphate phosphatase activity?
Myotubularin (MTM1) and several MTMR proteins, including MTMR2, MTMR3, MTMR4, MTMR6, MTMR7, MTMR8, and MTMR14, possess this activity.
How can I study phosphatidylinositol-3-phosphate phosphatase activity in the lab?
Common methods include in vitro phosphatase assays, PI3P biosensors for live imaging, autophagy flux analysis, and CRISPR knockout models.
What is the difference between PI3P phosphatase and PI3K?
PI3K adds a phosphate to phosphatidylinositol to generate PI3P, while PI3P phosphatase removes it, thus they have opposing functions.
Is phosphatidylinositol-3-phosphate phosphatase activity involved in cancer?
Yes, dysregulation of PI3P phosphatases can contribute to cancer, as they may act as tumor suppressors or modulate autophagy in tumor cells.
Can CRISPR be used to study phosphatidylinositol-3-phosphate phosphatase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect the function of MTMR genes and their role in disease.
Conclusion
Phosphatidylinositol-3-phosphate phosphatase activity (GO:0004438) is a fundamental enzymatic function that controls PI3P levels and thereby regulates autophagy, membrane trafficking, and signal transduction. Its importance is highlighted by severe human diseases caused by mutations in MTMR genes, such as X-linked myotubular myopathy and Charcot-Marie-Tooth disease. Continued research using advanced CRISPR models and biochemical assays will further illuminate the mechanistic details and therapeutic potential of targeting this activity.
References
- 1. Larabi A et al.. 2020. New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD.. Autophagy 16(1):38-51 PMID: 31286804
- 2. Ebner M et al.. 2023. Nutrient-regulated control of lysosome function by signaling lipid conversion.. Cell 186(24):5328-5346.e26 PMID: 37883971
- 3. Deneubourg C et al.. 2022. The spectrum of neurodevelopmental, neuromuscular and neurodegenerative disorders due to defective autophagy.. Autophagy 18(3):496-517 PMID: 34130600
- 4. Huang D et al.. 2025. An effector of phosphatidylinositol 3-kinase activity promotes Rickettsia rickettsii virulence by enhancing autophagy.. mBio 16(11):e0228425 PMID: 40980887
- 5. Srivastava S et al.. 2005. The phosphatidylinositol 3-phosphate phosphatase myotubularin- related protein 6 (MTMR6) is a negative regulator of the Ca2+-activated K+ channel KCa3.1.. Mol Cell Biol 25(9):3630-8 PMID: 15831468
- 6. Moschovaki-Filippidou F et al.. 2025. Lack of myotubularin phosphatase activity is the main cause of X-linked myotubular myopathy.. JCI Insight 10(22) PMID: 41086017
- 7. Basak B et al.. 2025. Mitochondrial damage triggers the concerted degradation of negative regulators of neuronal autophagy.. Nat Commun 16(1):7367 PMID: 40783388
- 8. Blondeau F et al.. 2000. Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway.. Hum Mol Genet 9(15):2223-9 PMID: 11001925
